Amgen(us:AMGN)

306.92

-1.49%

Updated on 2025-04-02

Open:310.58
Close:306.92
High:312.62
Low:305.00
Prev Close:311.55
Volume:3.04M
Turnover:936.19M
Turnover Ratio:0.57%
Shares:537.20M
MarketCap:164.88B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-30276741032334976.38%18911071125
2024-03-31273140397754175.31%16910881116
2023-12-31269340901010976.40%3089501108
2023-09-30251039842563974.46%239950978
2023-06-30243539681674374.18%1119471047
2023-03-31246039871572074.62%1149971000
2022-12-31248940407894875.67%2788201068
2022-09-30235440308981675.56%99918958
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Vanguard Group Inc518733669.66%-214844-0.41%
2024-06-30Blackrock Inc.460427298.57%-1928344-4.02%
2024-06-30State Street Corp289714815.39%-160831-0.55%
2024-06-30Primecap Management Co/Ca/144471272.69%-154831-1.06%
2024-06-30Morgan Stanley143624782.67%3905152.79%
2024-06-30Geode Capital Management, Llc120190382.24%3757303.23%
2024-06-30Charles Schwab Investment Management Inc102807531.91%-551589-5.09%
2024-06-30Capital International Investors83789601.56%137369119.61%
2024-06-30Wells Fargo & Company/Mn76775891.43%1749072.33%
2024-06-30Bank Of America Corp /De/60367621.12%270901081.41%

About

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Address:One Amgen Center Drive

Market Movers